|
|
| Research article summary (published 25 Nov 1987): |
Allergic reactions to drugs and biologic agents.
Full Abstract
In summary, the term adverse drug reaction is used to designate any type of undesirable and unintended response to a drug and can be broadly classified on the basis of either the presence or absence of an immune mechanism. Allergic reactions (immune) constitute only 5% to 10% of adverse drug reactions. Drug intolerance (nonimmune) constitutes the rest of these reactions. Many of these latter reactions are mild and self-limited, and many drug intolerances cannot be exactly characterized. Of those reactions in which an immune mechanism has been indicated or reactions that clinically appear to be "allergiclike," a limited number of in vivo (eg, skin tests) or in vitro (eg, RAST, IgE-ELISA, other antibody, or cell-mediated assays) tests have proved helpful in the diagnosis. Best studied are adverse reactions to aspirin, penicillin, insulin, and RCM. The principal treatment of all adverse drug reactions is to avoid the drug that has been specifically identified as being responsible for the previous reaction. In cases where avoidance is not possible, desensitization is an alternative (eg, penicillin and insulin). Prophylactic treatment of patients who had previously demonstrated a drug intolerance reaction (eg, systemic RCM reaction) with medication--particularly type I activation--may be helpful in some patients.
Author information
Author/s: Anderson, J A (JA); Adkinson, N F (NF);
Journal and publication information
Publication Type: Journal Article; Review
Journal: JAMA : the journal of the American Medical Association (JAMA), published in UNITED STATES. (Language: eng)
Reference: 1987-Nov; vol 258 (issue 20) : pp 2891-9
Dates: Created 1987/12/17; Completed 1987/12/17; Revised 2006/11/07;
PMID: 3312672, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Allergic reactions to drugs and biological agents.
23 Nov 1992 - Allergic reactions to drugs and biologic agents.
24 Nov 1982 - Adverse side-effects to biological agents.
30 Jul 2006 - Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?
29 Nov 2003 - Regulatory framework and requirements for managing risks associated with veterinary biological products in Africa: present systems and future needs.
29 Nov 1995 - [A composite report on the adverse reactions of drugs (author's transl)]
30 Dec 1978 - Biotechnology products in cancer therapy: a colloquium.
30 Dec 1987 - [Treatment of ulcer patients with a 30 percent alcohol solution of propolis]
30 Dec 1970 - Biologicals: test procedures available to assess components and products, with limitations.
29 Nov 1995
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.